Search alternatives:
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search), we decrease (Expand Search)
ng decrease » nn decrease (Expand Search), _ decrease (Expand Search), we decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a step » _ step (Expand Search)
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search), we decrease (Expand Search)
ng decrease » nn decrease (Expand Search), _ decrease (Expand Search), we decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a step » _ step (Expand Search)
-
1761
Exclusion in a 9-state-1-step CaM-CaMKII model.
Published 2019“…<p>For all traces, models are stimulated by a 2sec pulse of Ca<sup>2+</sup>. (A-C) Active CaMKII subunits over time in our 9-state-1-step model. …”
-
1762
High-throughput drug screen reveals HDAC and proteasome inhibitors as potent drug classes against synovial sarcoma.
Published 2017“…<p>(A) Compounds resulting in measured relative cell viability of less than 50% are annotated as hits (blue). …”
-
1763
-
1764
Lysine 50 of Tat regulates expression of C5, CRLF2, APBA1, and BDNF genes.
Published 2017“…<p>THP-1Tat-Flag and THP-1Tat K50ATat-Flag cell lines (generated from independent experiments described in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0179882#pone.0179882.g005" target="_blank">Fig 5</a>) were differentiated to macrophages with PMA for 24 and 48 hours. …”
-
1765
-
1766
-
1767
-
1768
HDAC inhibition prevents aggresome formation in response to proteasome inhibitors, and combination treatment leads to endoplasmic reticulum stress.
Published 2017“…<p>(A) Knockdown of HDAC6 results in decreased levels of LC3B in the SYO-1 synovial sarcoma cell line. …”
-
1769
-
1770
-
1771
-
1772
-
1773
DataSheet1_Greater than recommended stiffness and power setting of a stance-phase powered leg prosthesis can improve step-to-step transition work and effective foot length ratio du...
Published 2024“…People with TTA using a stance-phase powered prosthesis (e.g., BiOM, Ottobock, Duderstadt, Germany) walk with increased AL<sub>trail</sub> W<sub>pos</sub> and potentially decreased magnitude of UL<sub>lead</sub> W<sub>neg</sub> compared to a passive-elastic prosthesis. …”
-
1774
DataSheet4_Greater than recommended stiffness and power setting of a stance-phase powered leg prosthesis can improve step-to-step transition work and effective foot length ratio du...
Published 2024“…People with TTA using a stance-phase powered prosthesis (e.g., BiOM, Ottobock, Duderstadt, Germany) walk with increased AL<sub>trail</sub> W<sub>pos</sub> and potentially decreased magnitude of UL<sub>lead</sub> W<sub>neg</sub> compared to a passive-elastic prosthesis. …”
-
1775
DataSheet3_Greater than recommended stiffness and power setting of a stance-phase powered leg prosthesis can improve step-to-step transition work and effective foot length ratio du...
Published 2024“…People with TTA using a stance-phase powered prosthesis (e.g., BiOM, Ottobock, Duderstadt, Germany) walk with increased AL<sub>trail</sub> W<sub>pos</sub> and potentially decreased magnitude of UL<sub>lead</sub> W<sub>neg</sub> compared to a passive-elastic prosthesis. …”
-
1776
DataSheet2_Greater than recommended stiffness and power setting of a stance-phase powered leg prosthesis can improve step-to-step transition work and effective foot length ratio du...
Published 2024“…People with TTA using a stance-phase powered prosthesis (e.g., BiOM, Ottobock, Duderstadt, Germany) walk with increased AL<sub>trail</sub> W<sub>pos</sub> and potentially decreased magnitude of UL<sub>lead</sub> W<sub>neg</sub> compared to a passive-elastic prosthesis. …”
-
1777
-
1778
-
1779
-
1780